Related Experiment Video
Updated: Apr 21, 2026
08:49
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
Published on: January 13, 2023
2.5K
Liquid-liquid phase separation in cancer therapy resistance
Peng Hu1,2, Huaze Ding2, Ningning Yue3
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Iscience
|April 20, 2026
Summary
Liquid-liquid phase separation (LLPS) drives cancer's spread and resistance to treatment. Targeting these cellular condensates offers new strategies to overcome therapy failure in oncology.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Liquid-liquid phase separation (LLPS) is a fundamental cellular mechanism.
- LLPS is increasingly linked to cancer initiation, metastasis, immune evasion, and treatment resistance.
Purpose of the Study:
- To review how LLPS-derived condensates mediate cancer therapy resistance.
- To highlight therapeutic strategies targeting condensate dynamics for overcoming resistance.
Main Methods:
- Literature review synthesizing current research on LLPS in cancer therapy resistance.
- Analysis of mechanisms by which biomolecular condensates contribute to resistance.
- Identification of therapeutic approaches targeting LLPS.
Main Results:
- Aberrant biomolecular condensates are critical mediators of multiple therapy resistance pathways.
- LLPS contributes to cancer progression and evasion of therapeutic effects.
- Disrupting or exploiting condensate dynamics shows promise for reversing resistance.
Conclusions:
- LLPS plays a significant role in cancer therapy resistance.
- Targeting LLPS-mediated mechanisms presents a promising avenue for novel cancer therapies.
- This review provides a framework for future research and therapeutic development in oncology.
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:49Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
02:40Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K